Latest & greatest articles for chronic kidney disease

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on chronic kidney disease or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on chronic kidney disease and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for chronic kidney disease

121. Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease (PubMed)

Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease 28760941 2018 01 29 2018 11 13 1524-4563 70 4 2017 10 Hypertension (Dallas, Tex. : 1979) Hypertension Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease. 687-694 10.1161/HYPERTENSIONAHA.117.08314 Griffin Karen A KA From the Hines VA Hospital, IL; and Loyola University Medical Center, Maywood, IL. kgriffi@lumc.edu. eng R01 DK040426 DK NIDDK NIH HHS United States R01 DK061653 DK NIDDK NIH HHS United (...) States Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Review 2017 07 31 United States Hypertension 7906255 0194-911X IM Disease Progression Humans Hypertension complications physiopathology Renal Insufficiency, Chronic etiology physiopathology 2017 8 2 6 0 2018 1 30 6 0 2017 8 2 6 0 ppublish 28760941 HYPERTENSIONAHA.117.08314 10.1161/HYPERTENSIONAHA.117.08314 PMC5599324 NIHMS891429 Curr Opin Nephrol Hypertens. 2012 Jan;21(1):1-6 22048724 Hypertension

Full Text available with Trip Pro

2017 Hypertension (Dallas, Tex. : 1979)

122. Altered Protein Composition of Subcutaneous Adipose Tissue in Chronic Kidney Disease (PubMed)

Altered Protein Composition of Subcutaneous Adipose Tissue in Chronic Kidney Disease Loss of renal function is associated with high mortality from cardiovascular disease (CVD). Patients with chronic kidney disease (CKD) have altered circulating adipokine and nonesterified fatty acid concentrations and insulin resistance, which are features of disturbed adipose tissue metabolism. Because dysfunctional adipose tissue contributes to the development of CVD, we hypothesize that adipose tissue

Full Text available with Trip Pro

2017 Kidney international reports

123. Estimating One-Year Risk of Incident Chronic Kidney Disease: Retrospective Development and Validation Study Using Electronic Medical Record Data From the State of Maine (PubMed)

Estimating One-Year Risk of Incident Chronic Kidney Disease: Retrospective Development and Validation Study Using Electronic Medical Record Data From the State of Maine Chronic kidney disease (CKD) is a major public health concern in the United States with high prevalence, growing incidence, and serious adverse outcomes.We aimed to develop and validate a model to identify patients at risk of receiving a new diagnosis of CKD (incident CKD) during the next 1 year in a general population.The study

Full Text available with Trip Pro

2017 JMIR medical informatics

124. Management of Severe Hyponatremia With a Custom Continuous Renal Replacement Therapy in an Infant With Newly Diagnosed Chronic Kidney Disease (PubMed)

Management of Severe Hyponatremia With a Custom Continuous Renal Replacement Therapy in an Infant With Newly Diagnosed Chronic Kidney Disease 29270536 2019 02 26 2468-0249 2 6 2017 Nov Kidney international reports Kidney Int Rep Management of Severe Hyponatremia With a Custom Continuous Renal Replacement Therapy in an Infant With Newly Diagnosed Chronic Kidney Disease. 1254-1258 10.1016/j.ekir.2017.07.003 Gaudreault-Tremblay Marie-Michèle MM Division of Nephrology, The Hospital for Sick (...) of Toronto, Toronto, Ontario, Canada. Lemaire Mathieu M Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada. Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada. eng Case Reports 2017 07 20 United States Kidney Int Rep 101684752 2468-0249 2017 12 23 6 0 2017 12 23 6 0 2017 12 23 6 1 epublish 29270536 10.1016/j.ekir.2017.07.003 S2468-0249(17)30301-7 PMC5733878 J Am Soc Nephrol. 2012 Jul;23(7):1140-8 22626822 Pediatr Nephrol. 2010 Jul;25(7):1225-38

Full Text available with Trip Pro

2017 Kidney international reports

125. Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease (PubMed)

Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease Chronic kidney disease (CKD) patients have increased risks of sudden cardiac arrest and sudden cardiac death (SCA/SCD) that are not explained by traditional risk factors. We examined associations between serum potassium and SCA/SCD in a large cohort of patients with coronary artery disease (CAD) and moderate CKD.Among 22,009 patients who underwent cardiac

Full Text available with Trip Pro

2017 Kidney international reports

126. Effectiveness of pay-for-performance for chronic kidney disease patients on hemodialysis: a systematic review protocol. (PubMed)

Effectiveness of pay-for-performance for chronic kidney disease patients on hemodialysis: a systematic review protocol. The objective of this review is to assess the evidence on the effectiveness of implementation of a pay-for-performance program on clinical outcomes in the adult chronic kidney disease (CKD) patient receiving hemodialysis.The review question is: What is the effectiveness of implementation of a pay-for-performance program on clinical outcomes in the adult CKD patient receiving

2017 JBI database of systematic reviews and implementation reports

127. Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure (PubMed)

Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure This study investigated the relationship between the initial diuretic response to tolvaptan and clinical predictors for tolvaptan responders in patients with acute decompensated heart failure (ADHF).Patients (153) with ADHF (clinical scenario 2 or 3 with signs of fluid retention) who were administered tolvaptan were enrolled. Tolvaptan (15 or 7.5 mg) was administered for at least 7 days (...) to those patients in whom fluid retention was observed even after standard treatment. The maximum urine volume immediately after tolvaptan administration showed good correlations with the ejection fraction and estimated glomerular filtration rate that were independent predictors of the urine volume (UV) responders (≥1500 mL increase in urine volume). The diuretic response (in terms of maximum diuresis) diminished with advancing chronic kidney disease (CKD) stage and concomitant deterioration

Full Text available with Trip Pro

2017 ESC heart failure

128. Chronic kidney disease and the global NCDs agenda (PubMed)

Chronic kidney disease and the global NCDs agenda 29225940 2019 01 31 2059-7908 2 2 2017 BMJ global health BMJ Glob Health Chronic kidney disease and the global NCDs agenda. e000380 10.1136/bmjgh-2017-000380 Neuen Brendon Lange BL Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia. Renal and Metabolic Division, George Institute for Global Health, Sydney, Australia. Chadban Steven James SJ Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia (...) , Royal North Shore Hospital, Sydney, Australia. eng 001 World Health Organization International Editorial 2017 07 06 England BMJ Glob Health 101685275 2059-7908 Epidemiology Health systems Prevention strategies chronic kidney disease non-communicable diseases Competing interests: DWJ is Co-Chair of the International Society of Nephrology Global Kidney Care Atlas. AD is currently a staff member of the World Health Organization. The authors alone are responsible for the views expressed

Full Text available with Trip Pro

2017 BMJ global health

129. Interventions for chronic kidney disease in people with sickle cell disease. (PubMed)

Interventions for chronic kidney disease in people with sickle cell disease. Sickle cell disease (SCD) is one of the commonest severe monogenic disorders in the world, due to the inheritance of two abnormal haemoglobin (beta-globin) genes. SCD can cause severe pain, significant end-organ damage, pulmonary complications, and premature death. Kidney disease is a frequent and potentially severe complication in people with SCD.Chronic kidney disease is defined as abnormalities of kidney structure (...) assess the effectiveness of any intervention in preventing or reducing kidney complications or chronic kidney disease in people with SCD (including red blood cell transfusions, hydroxyurea and angiotensin-converting enzyme inhibitor (ACEI)), either alone or in combination with each other.We searched for relevant trials in the Cochrane Library, MEDLINE (from 1946), Embase (from 1974), the Transfusion Evidence Library (from 1980), and ongoing trial databases; all searches current to 05 April 2016. We

Full Text available with Trip Pro

2017 Cochrane

130. Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis

Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis Multiple frequency bioimpedance Multiple frequency bioimpedance de devices to guide fluid management in vices to guide fluid management in people with chronic kidne people with chronic kidney disease y disease ha having dialysis ving dialysis Diagnostics guidance Published: 21 June 2017 nice.org.uk/guidance/dg29 © NICE 2018. All rights reserved. Subject to Notice of rights (...) sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis (DG29) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 43Contents Contents 1 Recommendations 4 2 Clinical need and practice 5 The problem addressed 5

2017 National Institute for Health and Clinical Excellence - Diagnostics Guidance

131. Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker (PubMed)

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker CKD273 is a urinary biomarker, which in advanced chronic kidney disease predicts further deterioration. We investigated whether CKD273 can also predict a decline of estimated glomerular filtration rate (eGFR) to <60 ml/min per 1.73 m2.In analyses of 2087 individuals from 6 cohorts (46.4% women; 73.5% with diabetes; mean age, 46.1 years; eGFR ≥ 60 ml/min per 1.73 m2, 100%; urinary albumin excretion rate [UAE (...)  improved the net reclassification index (P ≤ 0.0003), except for UAE per threshold (P = 0.086).In conclusion, while accounting for baseline eGFR, albuminuria, and covariables, CKD273 adds to the prediction of stage 3 chronic kidney disease, at which point intervention remains an achievable therapeutic target.

Full Text available with Trip Pro

2017 Kidney international reports

132. Chronic Kidney Disease in Panama: Results From the PREFREC Study and National Mortality Trends (PubMed)

Chronic Kidney Disease in Panama: Results From the PREFREC Study and National Mortality Trends The magnitude of chronic kidney disease (CKD) in Panama has yet to be described. We investigated the association between sociodemographic and cardiovascular exposures with CKD in 2 Panamanian provinces. Further, we analyzed national trends of CKD mortality from 2001 to 2014.Data were derived from Prevalencia de Factores de Riesgo de Enfermedad Cardiovascular (PREFREC [Survey on Risk Factors Associated (...) With Cardiovascular Disease]), a cross-sectional study designed to analyze the prevalence of risk factors associated with cardiovascular disease. Biomarkers of kidney function were measured in 3590 participants. CKD was defined as an estimated glomerular filtration rate (eGFR) of <60 ml/min/1.73 m2 and/or albuminuria ≥30 mg/g creatinine. Odds ratios (ORs) with 95% confidence intervals (CIs) for CKD were calculated using logistic regression. We calculated age-standardized CKD mortality rates in the country using

Full Text available with Trip Pro

2017 Kidney international reports

133. Chronic kidney disease in low-income to middle-income countries: the case for increased screening (PubMed)

Chronic kidney disease in low-income to middle-income countries: the case for increased screening Chronic kidney disease (CKD) is fast becoming a major public health issue, disproportionately burdening low-income to middle-income countries, where detection rates remain low. We critically assessed the extant literature on CKD screening in low-income to middle-income countries. We performed a PubMed search, up to September 2016, for studies on CKD screening in low-income to middle-income (...) countries. Relevant studies were summarised through key questions derived from the Wilson and Jungner criteria. We found that low-income to middle-income countries are ill-equipped to deal with the devastating consequences of CKD, particularly the late stages of the disease. There are acceptable and relatively simple tools that can aid CKD screening in these countries. Screening should primarily include high-risk individuals (those with hypertension, type 2 diabetes, HIV infection or aged >60 years

Full Text available with Trip Pro

2017 BMJ global health

134. Re: Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases (PubMed)

Re: Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases 29142994 2019 01 18 2468-0249 2 4 2017 Jul Kidney international reports Kidney Int Rep Re: Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases. 779 10.1016/j.ekir.2017.05.005 Auguste Bourne L BL Division of Nephrology, University of Toronto, Toronto Ontario, Canada, on behalf of the University of Toronto (...) City-wide Nephrology Journal Club. Naimark David M J DMJ Division of Nephrology, University of Toronto, Toronto Ontario, Canada, on behalf of the University of Toronto City-wide Nephrology Journal Club. eng Journal Article 2017 05 12 United States Kidney Int Rep 101684752 2468-0249 2017 04 26 2017 05 05 2017 11 17 6 0 2017 11 17 6 0 2017 11 17 6 1 epublish 29142994 10.1016/j.ekir.2017.05.005 S2468-0249(17)30120-1 PMC5678618 J Am Soc Nephrol. 2003 Nov;14(11):2934-41 14569104 J Am Soc Nephrol. 2009

Full Text available with Trip Pro

2017 Kidney international reports

135. The Association of Daily Activity Levels and Estimated Kidney Function in Men and Women With Predialysis Chronic Kidney Disease (PubMed)

The Association of Daily Activity Levels and Estimated Kidney Function in Men and Women With Predialysis Chronic Kidney Disease Chronic kidney disease (CKD) is often accompanied by complications including poor physical activity level. However, only a few studies have objectively characterized physical activity levels in predialysis CKD. Our study sought to measure daily activity levels by accelerometry in individuals with CKD (stages III-V) and to determine the association between daily (...) activity and kidney function.We determined kidney function by means of the estimated glomerular filtration rate (eGFR) using the Modification of Diet and Renal Disease (MDRD) equation. Participants wore an accelerometer for 7 consecutive days, and we measured multiple physical activity outcomes including total daily activity, sedentary, light, and moderate-vigorous activity. Average durations and intensity of activity were determined according to stage of CKD. The association between kidney function

Full Text available with Trip Pro

2017 Kidney international reports

136. Association of Sleep Duration, Symptoms, and Disorders With Mortality in Adults With Chronic Kidney Disease (PubMed)

Association of Sleep Duration, Symptoms, and Disorders With Mortality in Adults With Chronic Kidney Disease In general populations, short and long sleep duration, poor sleep quality and sleep disorders have been associated with increased risk of death. We evaluated these associations in individuals with chronic kidney disease (CKD).Prospective cohort study of 1,452 National Health and Nutrition Examination Survey (NHANES) 2005-2008 participants with CKD. CKD was defined by estimated glomerular

Full Text available with Trip Pro

2017 Kidney international reports

137. Examining the Roles and Experiences of Fathers of Children With Chronic Kidney Disease (PubMed)

Examining the Roles and Experiences of Fathers of Children With Chronic Kidney Disease This study examined roles and experiences of fathers of children with chronic kidney disease (CKD). Based on interpretive description, semistructured interviews were conducted with 22 fathers of children receiving a range of treatments (transplant, peritoneal dialysis, hemodialysis, and CKD not requiring renal replacement therapy). Fathers described various experiences and means of adjusting to shifts

Full Text available with Trip Pro

2017 Global qualitative nursing research

138. Dietary interventions for adults with chronic kidney disease. (PubMed)

Dietary interventions for adults with chronic kidney disease. Dietary changes are routinely recommended in people with chronic kidney disease (CKD) on the basis of randomised evidence in the general population and non-randomised studies in CKD that suggest certain healthy eating patterns may prevent cardiovascular events and lower mortality. People who have kidney disease have prioritised dietary modifications as an important treatment uncertainty.This review evaluated the benefits and harms (...) of dietary interventions among adults with CKD including people with end-stage kidney disease (ESKD) treated with dialysis or kidney transplantation.We searched the Cochrane Kidney and Transplant Specialised Register (up to 31 January 2017) through contact with the Information Specialist using search terms relevant to this review. Studies contained in the Specialised Register are identified through search strategies specifically designed for CENTRAL, MEDLINE, and EMBASE; handsearching conference

Full Text available with Trip Pro

2017 Cochrane

139. Screening for Chronic Kidney Disease in Adult Males in Vojvodina: A Cross-sectional Study (PubMed)

Screening for Chronic Kidney Disease in Adult Males in Vojvodina: A Cross-sectional Study Chronic kidney disease (CKD) is one of the most significant global health problems accompanied by numerous complicatons, with constant increase in the number of affected people. This number is much higher in early phases of disease and patients are mostly asymptomatic, so early detection of CKD is crucial. The aim was examination of the prevalence of CKD in the general population of males in Vojvodina (...) are the most important CKD risk factors and the level of CKD awareness is extremely low (1.3%) indicating the necessity for introduction of early stage disease recognition measures, including raising CKD awareness.

Full Text available with Trip Pro

2017 Journal of medical biochemistry

140. Interpretation of Erythropoietin and Haemoglobin Levels in Patients with Various Stages of Chronic Kidney Disease (PubMed)

Interpretation of Erythropoietin and Haemoglobin Levels in Patients with Various Stages of Chronic Kidney Disease The production of erythrocytes is regulated by the hormone erythropoietin (EPO), which maintains the blood haemoglobin (Hb) levels constant under normal conditions. Human EPO is a glycoprotein hormone and its synthesis is controlled by the hypoxia-inducible transcription factor. The aim of this study was to establish EPO and Hb levels in patients with chronic kidney disease (CKD

Full Text available with Trip Pro

2017 Journal of medical biochemistry